J Nick Riehle
CIK 1316746 · Chief Financial Officer · last filed 2025-09-10
J Nick Riehle is a Chief Financial Officer who has filed 16 SEC Form 4 insider transactions across 2 companies since 2007. Across all open-market trades the lifetime net is +$42.8K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
16
$42.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Athenex, Inc. (ATNX) Delisted | Chief Financial Officer | 1,500 | $0.20 | $305 | $16.5K | 3 | 2018-08-21 |
| Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Chief Financial Officer | 66,183 | — | — | $26.3K | 12 | 2014-01-24 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-10 | — | Grant (A) | — | $0 | |
| 2018-08-21 | Athenex, Inc. (ATNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-07-28 | Athenex, Inc. (ATNX) Delisted | Buy (P) | +1,500 | $16.5K | EDGAR |
| 2017-06-21 | Athenex, Inc. (ATNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-01-24 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-01-09 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-07-11 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-01-27 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-01-13 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-11-05 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Buy (P) | +3,000 | $14.5K | EDGAR |